Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage of anti-obesity drugsThe Trump administration says it will ...

Eastern states took the top spots on WalletHub's rankings of "best" states for children's health. Here's where Washington ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

WASHINGTON -- The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 ...

The U.S. obesity rate is about 40%, according to a 2021-2023 survey of about 6,000 people. Nearly 1 in 10 of those surveyed reported severe obesity, the U.S. Centers for Disease Control and Prevention ...

Kennedy Jr. to keep a proposed Biden-era rule that would have allowed Medicare and Medicaid to cover drugs used to treat obesity after the Trump administration decided not to finalize it.

Novo Nordisk's hopes of heralding a new era of obesity treatment with its CagriSema drug have been called into question after a series of trial results sent shares falling. Headline results from a ...

Obesity is associated with longer operative ... Childers, MD, PhD, Department of Surgery, University of Washington, Seattle. It was published online in the Journal of the American College of ...

Copenhagen, DENMARK — Novo Nordisk defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an "important" weight loss ...